Skip to content

Access Free T4 Reagents on the Access Immunoassay Analyzer

by Beckman Instruments, Inc. 510(k)

Active United States

510(k) K982250

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK982250 Date14 Jul 1998ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

4 recalls · FDA

    • Terminated Z-2237-2020 FDA Class II initiated 30 Apr 2019

    The recalling firm characterized the potential interference effects of biotin (up to 1,200 ng/mL) on all biotin-mediated Access assays. The following six assays: Free T3-REF A13422, Total T3-REF 33830, Free T4-REF 33880, GI Mon-387687, Tg-REF 33860, and TgAbII-REF A32898 displayed significant interference (defined as a result bias greater than +/-10%) at 1,200 ng/mL of biotin.

    • Terminated Z-2637-2017 FDA Class II initiated 9 May 2017

    The Access immunoassays are susceptible to biotin interference.

    • Terminated Z-1945-2011 FDA Unclassified (pre-2012) initiated 11 Nov 2010

    The recall was initiated because the stability claim for Access Free T4 calibrator lot 014769 is not met. The affected T4 calibrator lot can produce quality control and patient results that are erroneously low (by greater than 2 standard deviations). An erroneously low patient result may lead to misdiagnosis and/or delayed treatment.

    • Terminated Z-2658-2010 FDA Unclassified (pre-2012) initiated 24 Mar 2010

    The recall was initiated after Beckman Coulter determined that kit boxes for Access Free T4 reagent (REF 33880), lot number 916293 may contain reagent packs labeled as Access Vitamin B12, (REF 33000), lot 916277. Using an Access Vitamin B12 reagent pack, lot 916277, filled with Access Free T4 reagents may generate incorrect patient results.

Specification

510(k)

510(k) Number
FDA Product Code
CEC
Device Class
Class II
Regulation
21 CFR Part 862.1695
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Beckman Instruments, Inc.

See all devices from Beckman Instruments, Inc. →